The role of the IL23/IL17 pathway in inflammatory bowel disease by Geremia, A

The role of genetics in Crohn's disease: how could it influence future therapies? by Geremia, A, Satsangi, J

Innate lymphoid cells in intestinal inflammation by Geremia, A, Arancibia-Cárcamo, C

Host-microbial crosstalk in the pathogenesis of colon cancer in Primary sclerosing cholangitis by Neyazi, M, Oxford IBD cohort study investigators, Travis, S, Arancibia, C, Powrie, F, Geremia, A

IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. by Geremia, A, Arancibia-Cárcamo, C, Fleming, M, Rust, N, Singh, B, Mortensen, N, Travis, S, Powrie, F

Association of caspase-9 and RUNX3 with inflammatory bowel disease. by Guo, C, Ahmad, T, Beckly, J, Cummings, JR, Hancock, L, Geremia, A, Cooney, R, Pathan, S, Jewell, D

OP28 Host–microbial crosstalk in the pathogenesis of inflammation and cancer in primary sclerosing cholangitis by Neyazi, M, Ilott, N, Oxford IBD Cohort Study Investigators, Travis, S, Arancibia, C, Powrie, F, Geremia, A

Association between genetic variants in myosin IXB and Crohn's disease. by Cooney, R, Cummings, JR, Pathan, S, Beckly, J, Geremia, A, Hancock, L, Guo, C, Morris, A, Jewell, D

Two-stage candidate gene study of chromosome 3p demonstrates an association between nonsynonymous variants in the MST1R gene and Crohn's disease. by Beckly, J, Hancock, L, Geremia, A, Cummings, JR, Morris, A, Cooney, R, Pathan, S, Guo, C, Jewell, D

Th1 and innate lymphoid cells accumulate in primary sclerosing cholangitis-associated inflammatory bowel disease by Gwela, A, Siddhanathi, P, Oxford IBD Cohort Investigators, Chapman, R, Travis, S, Powrie, F, Arancibia-Cárcamo, C, Geremia, A

Extensive weight loss reduces glycan age by altering IgG N-glycosylation by Greto, VL, Cvetko, A, Štambuk, T, Dempster, NJ, Gillies, RS, Tomlinson, JW, Sgromo, B, Geremia, A, Arancibia-Cárcamo, CV

Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype. by Cummings, JR, Ahmad, T, Geremia, A, Beckly, J, Cooney, R, Hancock, L, Pathan, S, Guo, C, Cardon, L, Jewell, D

The genetics of NOD-like receptors in Crohn's disease. by Cummings, JR, Cooney, R, Clarke, G, Beckly, J, Geremia, A, Pathan, S, Hancock, L, Guo, C, Cardon, L, Jewell, D

Confirmation of the role of ATG16L1 as a Crohn's disease susceptibility gene. by Cummings, JR, Cooney, R, Pathan, S, Anderson, C, Barrett, J, Beckly, J, Geremia, A, Hancock, L, Guo, C, Ahmad, T, Cardon, L, Jewell, D

A novel serum metabolomic panel distinguishes IgG4-related sclerosing cholangitis from primary sclerosing cholangitis by Radford-Smith, DE, Selvaraj, EA, Peters, R, Orrell, M, Bolon, J, Anthony, DC, Pavlides, M, Lynch, K, Geremia, A, Bailey, A, Culver, EL, Probert, F

Lymphocyte activation gene (LAG)-3 on T cells is a potential therapeutic target in ulcerative colitis by Slevin, S, Tan, M, Lahiff, C, Wang, L, Greenaway, B, Lynch, K, Geremia, A, Hughes, S, Leavens, K, Nevin, K, Marks, D, Tarzi, R, Srinivasan, N, Travis, S, Arancibia, C, Keshav, S

Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8 + T cells by Walker, L, Kang, Y, Smith, M, Tharmalingham, H, Ramamurthy, N, Fleming, V, Sahgal, N, Leslie, A, Oo, Y, Geremia, A, Scriba, T, Hanekom, W, Lauer, G, Lantz, O, Adams, D, Powrie, F, Barnes, E, Klenerman, P

Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells. by Walker, L, Kang, Y, Smith, M, Tharmalingham, H, Ramamurthy, N, Fleming, V, Sahgal, N, Leslie, A, Oo, Y, Geremia, A, Scriba, T, Hanekom, W, Lauer, G, Lantz, O, Adams, D, Powrie, F, Barnes, E, Klenerman, P

CD161 defines a functionally distinct subset of pro-inflammatory natural killer cells by Kurioka, A, Cosgrove, C, Simoni, Y, van Wilgenburg, B, Geremia, A, Björkander, S, Sverremark-Ekström, E, Thurnheer, C, Günthard, H, Khanna, N, Swiss HIV Cohort Study (50 Others), Oxford IBD Cohort Investigators et al., Walker, L, Arancibia-Cárcamo, C, Newell, E, Willberg, C, Klenerman, P

IL-1-driven stromal–neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies by Friedrich, M, Pohin, M, Jackson, MA, Korsunsky, I, Bullers, SJ, Rue-Albrecht, K, Christoforidou, Z, Sathananthan, D, Thomas, T, Ravindran, R, Tandon, R, Peres, RS, Sharpe, H, Wei, K, Watts, GFM, Mann, EH, Geremia, A, Attar, M, Barone, F, Brenner, M, Buckley, CD, Coles, M, Frei, AP, Lassen, KG, Powrie, FM, McCuaig, S, Thomas, L, Collantes, E, Uhlig, HH, Sansom, SN, Easton, A, Raychaudhuri, S, Travis, SP, Powrie, FM